Why Changes are needed to Current Preformulation and Formulation PracticesHosted By : Andrea Charles
March 15, 2011
About this Podcast...
As part of the Pharma Leaders Today Series Dr. Keith Horspool, Vice President, Pharmaceutical Development US, Boehringer Ingelheim, speaks to Andrea Charles from Pharma IQ, about why changes are needed to current preformulation and formulation practices, strategies to reduce time spent in R&D and importance of the role of co-crystals in formulation design and product development.
Horspool also shares his top 3 tips for evaluating the potential of new drug delivery technologies.
Have Your Say
Rate this feature and give us your feedback in the comments section below